Rheumatology is the study which diagnoses and finds therapies to treat rheumatic diseases such as arthritis, gout, lupus, Lyme. It is also associated with pain disorders in joints, ligaments, muscles. Therapeutics refer tothe usage of drugs as medicines for the treatment of rheumatic diseases, and the route of administrating it.Rheumatic disease is a major burden around the world. It can occur to anyone regardless of gender, and age.
The rise of geriatric population along with the global occurrence of rheumatoid diseases are propelling the growth of the Rheumatology Therapeutics market. The growing awareness of rheumatology therapies among the population and the cost-effective nature of these treatments are expected to make a positive impact on the Rheumatology Therapeutics market. Another major factor driving the growth of the global Rheumatology Therapeutics market is the swift acceptance of new drugs for the treatment of different types of rheumatic diseases.Furthermore, growing investment in R&D is estimated to strengthen the market for global rheumatology therapeutics. Moreover, the introduction of technologically enhanced products such as biosimilars, and biologics are boosting the demand of this market.
Rheumatology Therapeutics market has been bifurcated as drug types, disease types, the method of administration, distribution channel, and geographical segmentation. Based on drug types, the market for rheumatology therapeutics is analyzed as Disease Modifying Anti-Rheumatic Drugs, Cortisteroids, Non-Steroidal Anti-Inflammatory Drugs, Immunosuppressants, and Biologics. Moreover, based on disease types, the market is segmented as Rheumatoid Arthritis, Gout, Osteoarthritis, Juvenile Idiopathic Arthritis, Scleroderma, Sjogren’s Syndrome, and others. The method ofadministration forRheumatology Therapeutics mentioned in the report includes topical, oral, and parenteral administration. Moving forward, the channel of distribution includes hospital, online, and retail. The globalRheumatology Therapeutics market has been moreover segmented geographically into North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.
Further down, among the different drug types of Rheumatology Therapeutics, the DMARD’s- Disease Modifying Anti-Rheumatic Drugs are leading the market owing to the rise in usage during the early stage of treatment, and adoption of biological drugs to treatrheumatoid arthritis. Corticosteroids are estimated to witness a significant growth over the projection period. Based on the different disease types of Rheumatology Therapeutics, Rheumatoid Arthritis disease accounts for the leading rate of prevalence in the market as compared to other diseases.
North-Americaaccounts for the largest market share for the rheumatology therapeutics market owing to the rise of geriatric population, and adoption of biologic products. Europe is the other leading regional market after North-America. The growth in this region is mainly attributed to the advanced infrastructure of the healthcare system, and the rise of rheumatic diseases. Asia-Pacific is estimated to have a slow and promising growth over the projection period. The growth for the Asia-Pacific region may be attributed to hectic lifestyle, lack of physical activity and obesity. Latin-America and Middle East & Africa are estimated to witness a steady growth over the forecasted years owing to the rise of rheumatic diseases, and healthcare infrastructure.
However, stringent regulations, high capital investments in developing new drugs, adoption of biosimilars, and generics may slower the growth of the global rheumatology therapeutics market over the projection period.
The major key players in the global Rheumatology Therapeutics marketinclude Sanofi, Takeda Pharmaceuticals, AbbVie Inc., Pfizer Inc., Bristol-Myers Squibb Company, Amgen inc., Janssen Biotec Inc., Novartis AG, and Regeneron Pharmaceutical Inc.
Global Rheumatology Therapeutics Market: By Drug Types
Global Rheumatology Therapeutics Market: By Disease Types
Global Rheumatology Therapeutics Market: By Method of Administration
Global Rheumatology Therapeutics Market: By Distribution Channel
Global Rheumatology Therapeutics Market: By Geography